20 related articles for article (PubMed ID: 6184548)
1. Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis.
Anh NH; Long NP; Kim SJ; Min JE; Yoon SJ; Kim HM; Yang E; Hwang ES; Park JH; Hong SS; Kwon SW
Metabolites; 2019 Sep; 9(10):. PubMed ID: 31546652
[TBL] [Abstract][Full Text] [Related]
2. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
[TBL] [Abstract][Full Text] [Related]
3. [Testosterone and the prostate].
Sperling H; Rossi R; Lümmen G; Rübben H
Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
[TBL] [Abstract][Full Text] [Related]
4. Perinatal characteristics in relation to incidence of and mortality from prostate cancer.
Ekbom A; Hsieh CC; Lipworth L; Wolk A; Pontén J; Adami HO; Trichopoulos D
BMJ; 1996 Aug; 313(7053):337-41. PubMed ID: 8760741
[TBL] [Abstract][Full Text] [Related]
5. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study.
Andersson SO; Adami HO; Bergström R; Wide L
Br J Cancer; 1993 Jul; 68(1):97-102. PubMed ID: 8318428
[TBL] [Abstract][Full Text] [Related]
6. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men.
Honda GD; Bernstein L; Ross RK; Greenland S; Gerkins V; Henderson BE
Br J Cancer; 1988 Mar; 57(3):326-31. PubMed ID: 3355774
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes of plasma steroids in normal adult males.
Drafta D; Schindler AE; Stroe E; Neacşu E
J Steroid Biochem; 1982 Dec; 17(6):683-7. PubMed ID: 7176658
[TBL] [Abstract][Full Text] [Related]
8. The effects of endocrine therapy on plasma steroids in prostatic carcinoma patients.
Drafta D; Proca E; Schindler AE; Neacşu E; Zamfir V; Neagoe M; Teodosiu D
Endocrinologie; 1984; 22(3):191-7. PubMed ID: 6494786
[TBL] [Abstract][Full Text] [Related]
9. Serum steroids in normal males and patients with prostatic diseases.
Hammond GL; Kontturi M; Vihko P; Vihko R
Clin Endocrinol (Oxf); 1978 Aug; 9(2):113-21. PubMed ID: 81115
[TBL] [Abstract][Full Text] [Related]
10. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
Vermeulen A; De Sy W
J Clin Endocrinol Metab; 1976 Dec; 43(6):1250-4. PubMed ID: 63468
[TBL] [Abstract][Full Text] [Related]
11. Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
Meunier ME; Neuzillet Y; Raynaud JP; Radulescu C; Ghoneim T; Fiet J; Giton F; Rouanne M; Dreyfus JF; Lebret T; Botto H
Prostate; 2019 Feb; 79(3):272-280. PubMed ID: 30370569
[TBL] [Abstract][Full Text] [Related]
12. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
